The Alexandria Seed Capital Platform brings together leaders from across the life science community to catalyze seed-stage investment in the most promising life science startups. This unique platform will be led by Alexandria Venture Investments and supported by a preeminent Advisory Board of seasoned biopharma and venture capital executives from Accelerator Life Science Partners, ARCH Venture Partners, Eli Lilly and Company, Pfizer, and Roche.
Seed-stage investment opportunities are sourced directly from Alexandria LaunchLabs and the Alexandria national network. Sectors of interest include novel drug discovery platforms, diagnostics, medical technologies, and bioinformatics-driven healthcare solutions.APPLY NOW
Funding decisions are made based on the quality and differentiation of a company’s technology, foundational IP, business strategy, financing plan, and management team.